Literature DB >> 29453702

The relationship between local recurrences and distant metastases in prostate cancer: can 11C-choline PET/CT contribute to understand the link?

Giampiero Giovacchini1, Andrea Ciarmiello1, Elisabetta Giovannini1, Andrei Fodor2, Cesare Cozzarini2, Paola Mapelli3,4, Elena Incerti3, Nadia Di Muzio2, Luigi Gianolli3, Maria Picchio5,6.   

Abstract

PURPOSE: Previous studies in prostate cancer (PCa) patients tried to correlate the onset of local recurrence (LR) with the development of distant metastases and formulated, based on theoretical and experimental data, hypotheses linking the two events. We aimed to address this issue with 11C-choline positron emission tomography/computed tomography (PET/CT).
METHODS: This retrospective study included 491 PCa patients previously treated with radical prostatectomy who had undergone 11C-choline PET/CT owing to biochemical failure. Further inclusion criteria were availability of clinical and pathological variables for survival analysis. Statistical significance was taken at P < 0.05.
RESULTS: Seventy-two patients (14.7%) had evidence of LR at 11C-choline PET/CT. The frequency of LR increased from 13.8% in the interval 0-4 years after prostatectomy, to 23.9% in the 12-16-year interval (P = 0.080). On the contrary, the frequency of lymph node metastases (overall rate in the 0-16 years interval after prostatectomy: 26.3%) and of bone metastases (overall rate: 13.8%) decreased significantly over time. Kaplan-Meier curves showed no significant group difference in the rates of lymph node or bone metastases between patients with LR and patients without LR. LR significantly predicted PCa-specific survival at univariate analysis, but the statistical significance was lost at multivariate analysis.
CONCLUSION: We found no differences in the rates of lymph node and bone metastases between patients with and without LR. An inverse time-dependent trend was observed in the frequency of LR on one side and of lymph node and bone metastases on the other side. These findings were discussed in relation to previous theories linking LR to distant metastases and our study design.

Entities:  

Keywords:  11C-choline; Biochemical failure; Distant metastases; Local recurrence; Positron emission tomography/computed tomography; Prostate cancer

Mesh:

Substances:

Year:  2018        PMID: 29453702     DOI: 10.1007/s00259-018-3944-0

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  33 in total

1.  Influence of PSA, PSA velocity and PSA doubling time on contrast-enhanced 18F-choline PET/CT detection rate in patients with rising PSA after radical prostatectomy.

Authors:  Orazio Schillaci; Ferdinando Calabria; Mario Tavolozza; Cristiana Ragano Caracciolo; Enrico Finazzi Agrò; Roberto Miano; Antonio Orlacchio; Roberta Danieli; Giovanni Simonetti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-01-10       Impact factor: 9.236

2.  18F choline PET/CT in the preoperative staging of prostate cancer in patients with intermediate or high risk of extracapsular disease: a prospective study of 130 patients.

Authors:  Mohsen Beheshti; Larisa Imamovic; Gabriele Broinger; Reza Vali; Peter Waldenberger; Franz Stoiber; Michael Nader; Bernhard Gruy; Guenter Janetschek; Werner Langsteger
Journal:  Radiology       Date:  2010-03       Impact factor: 11.105

3.  (11)C-Choline PET/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series.

Authors:  Tiziano Graziani; Francesco Ceci; Paolo Castellucci; Giulia Polverari; Giacomo Maria Lima; Filippo Lodi; Alessio Giuseppe Morganti; Andrea Ardizzoni; Riccardo Schiavina; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-06-08       Impact factor: 9.236

4.  Gleason score at diagnosis predicts the rate of detection of 18F-choline PET/CT performed when biochemical evidence indicates recurrence of prostate cancer: experience with 1,000 patients.

Authors:  Marino Cimitan; Laura Evangelista; Marina Hodolič; Giuliano Mariani; Tanja Baseric; Valentina Bodanza; Giorgio Saladini; Duccio Volterrani; Anna Rita Cervino; Michele Gregianin; Giulia Puccini; Federica Guidoccio; Jure Fettich; Eugenio Borsatti
Journal:  J Nucl Med       Date:  2014-12-31       Impact factor: 10.057

5.  Effect of local tumor control on distant metastasis and survival in prostatic adenocarcinoma.

Authors:  D A Kuban; A M el-Mahdi; P F Schellhammer
Journal:  Urology       Date:  1987-11       Impact factor: 2.649

6.  Moderate Hypofractionation with Simultaneous Integrated Boost in Prostate Cancer: Long-term Results of a Phase I-II Study.

Authors:  N G Di Muzio; A Fodor; B Noris Chiorda; S Broggi; P Mangili; R Valdagni; I Dell'Oca; M Pasetti; C L Deantoni; A Chiara; G Berardi; A Briganti; R Calandrino; C Cozzarini; C Fiorino
Journal:  Clin Oncol (R Coll Radiol)       Date:  2016-03-05       Impact factor: 4.126

7.  Radical radiation for localized prostate cancer: local persistence of disease results in a late wave of metastases.

Authors:  John J Coen; Anthony L Zietman; Harjot Thakral; William U Shipley
Journal:  J Clin Oncol       Date:  2002-08-01       Impact factor: 44.544

8.  (11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy.

Authors:  Francesco Ceci; Paolo Castellucci; Marcelo Mamede; Riccardo Schiavina; Domenico Rubello; Chiara Fuccio; Valentina Ambrosini; Stefano Boschi; Giuseppe Martorana; Stefano Fanti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-11-14       Impact factor: 9.236

9.  The detection rate of [11C]choline-PET/CT depends on the serum PSA-value in patients with biochemical recurrence of prostate cancer.

Authors:  B J Krause; M Souvatzoglou; M Tuncel; K Herrmann; A K Buck; C Praus; T Schuster; H Geinitz; U Treiber; M Schwaiger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09-22       Impact factor: 9.236

10.  Detection of bone metastases in patients with prostate cancer by 18F fluorocholine and 18F fluoride PET-CT: a comparative study.

Authors:  Mohsen Beheshti; Reza Vali; Peter Waldenberger; Friedrich Fitz; Michael Nader; Wolfgang Loidl; Gabriele Broinger; Franz Stoiber; Ignac Foglman; Werner Langsteger
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-05-09       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.